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The interaction between hemoglobin and oxygen which occurs 
in the lung is necessary for life, but in those with sickle cel 
disease, it has an added, critical importance. Deoxygenation, 
acidosis, and hypertonicity all favor sickling of erythrocytes 
carrying the abnormal S hemoglobin. If the blood is not 
sufficiently oxygenated in the lungs, arterial PG^ will drop. 
Below a critical PO2 extensive sickling in the microvasculature 
of the tissues occurs. In many patients a small, but constant 
percentage of the circulating erythrocytes is always sickled 
(Milner, 1974). Sickled erythrocytes may occlude the vascular 
channels, resulting in oxygen deprivation of the tissues, more 
sickling, and eventually infarction. 
The significance of sickling and its effect on the spleen, 
leading to autoinfarction, and on the kidney, resulting in loss 
of concentrating ability, have been well documented. However, 
the effect of sickling on the lungs, which receive the most 




The first portion of this paper reviews the literature 
on pulmonary disease in sickle cell anemia. The second portion 
consists of a clinical study which 1) Presents clinical data on 
pulmonary episodes in sickle ceil patients seen at Yale- 
New Haven Hospital and 2) Examines pulmonary function in 
asymptomatic patients with sickle cell disease. 
This study will document that there is a high incidence of 
acute pulmonary disease in the sickle cell population and 
will delineate the characteristics of pneumonia in this 
population. Pulmonary function studies documenting an 
impairment in gas exchange will be described. The hypothesised 
underlying pathophysiology of pulmonary disease in the sickle 
cell population will be discussed. Lastly problems of management 
of acute pulmonary disease in the sickler and the direction 
of further studies will be examined. 
Literature Review 
It is known that those with sickle call anemia are more 
prone to pneumonia, and also that they may have episodes of 
pulmonary infarction. Distinguishing acutely between infarction 
and pneumonia frequently constitutes a diagnostic dilemma. In 
addition the acute and chronic effects of sickling on the lungs 
are not well established. It has been reported the sickle cell 
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patients have impaired lung function and progress to develop 
cor pulmonale, but there is controversy regarding the frequency 
of this complication. In the following section of this thesis 
the literature on pulmonary manifestations of sickle cell 
disease will be examined with regards to: 1) Infection, 
2) Infarction, 3) Radiographic changes, 4) Cardiovascular 
function, 5) Pulmonary function, and 6) Pulmonary pathology. 
Infection 
An acute pulmonary event is the most common cause of 
hospitalization in the sickle population (Barrett-Connor, 1971-b) 
The relative incidence of pneumonia in the sickle population 
is at least 20 to 100 times that in normal blacks (Bromberg, 
1974; Barrett-Connor, 1971-a). Of 54 sickle cell patients 
(mean age 21.2, range 5 to 50) reviewed by Henderson, there 
were 105 admissions to the medical service over a ten year 
period. Of these 14 were for pneumonia and 13 had an 
associated crisis. Barrett-Connor reported that for 166 
patients with sickle cell disease followed ever a period of 
11 years (average of 5 years, with a total of 864 patient-years) 
there were 200 hospitalizations for an acute illness with an 
infiltrate on chest x-ray (Barrett-Connor, 1971-a). This 
population was somewhat younger than Henderson's, 
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with a mean age of 12 and a range of 7 weeks to 47 years. In 
another study 98 sickle cell patients had 63 episodes of 
bronchopneumonia occurring in 42 of the group (Karaylacin et 
al. , 1975). Clearly the incidence of acute pulmonary disease 
is significantly increased in sickle cell anemia. 
The clinical manifestations of acute pulmonary disease 
in sickle cell anemia differ from those of the normal population. 
Consistently prolonged fever, lasting as long as 41 days, 
characterizes pneumonia in patients with sickle cell anemia. 
(Petch and Serjeant, 1970; Petch et al., 1970; Barrett-Connor, 
1973; Henderson, 1950). Frequently there is a history of 
previous pneumonia, and if pneumonia occurs before the age 
of 5 the individual is more likely to have recurrent episodes 
(i c uCu 6 c d-L. , zt / G; cdire ct-vOniioi , i ^ /1 —a) » n i s co j. y o 
preceding upper respiratory tract .infection is common. 
Sputum and blood cultures are often negative, and antibiotic 
response is inconclusive. The white blood count reaches higher 
levels in sickle cell patients with pneumonia versus 
controls with pneumonia. Petch et al. (1970) found on admission 
mean white counts of 23,400/mm' with a range of 9,300 to 
52,000/mm in sicklers versus age-matched controls with mean 
white counts on admission of 12,500/mm with a range of 5,100 
to 34,000/mm^. In addition to the prolonged course of fever 
and high white blood cell counts, sickle cell patients also 
tend to have repeated bouts of pneumonia during one 
hospitalization. Frequently more than one lobe is involved; 




Mycoplasma pneumonia tends to be particularly severe in 
patients with sickle cell anemia. Shulman et. al. (1972) 
reported 5 cases of mycoplasma in children. The illnesses 
were characterized by multi],obar involvement, white blood 
**■> 
counts greater than 25,000/mmo (versus the usual absence of 
leukocytosis in normal patients with mycoplasma), a prolonged 
fever course of greater than 7 days, pleuritic pain, and 
pleural effusion in 2 out of the 5 cases. Significantly no 
dramatic response to erythromycin occurred, although the cases 
were all well-documented with a rise in cold agglutinin titer, 
positive cold agglutinins, and/or a positive mycoplasma 
complement fixation titer. The increased severity of mycoplasma 
pneumonia in patients with sickle cell disease was also 
noted by Putnam et al. in their review of radiological 
manifestations of mycoplasma (Putnam et al., 1975). 
There is increasing evidence that patients with sickle 
cell disease have impaired antimicrobial defense systems. 
Pearson et al. have documented that at an early age sickle 
cell patients have a functional asplenia (Pearson et al., 1.969 ; 
Pearson et al., 1970). Sickle cell patients are particularly 
susceptible to pneumococcal infection (Barrett-Connor, 1971-b). 
Studies of serum from sickle cell patients versus normal 
controls demonstrated that the sickle cell serum has abnormally 
low levels of heat-labile opsonizing activity for the pneumo¬ 
coccus. On the other hand the levels of serum opsonizing 
— 
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activity for salmonella do not differ significantly between 
the two groups, and both groups have similar hemolytic 
complement activity (Winkelstein and Drachman, 1968). 
In vitro leukocyte phagocytosis in both groups is 
indistinguishable. Johnston et al.'s work indicates that 
the defect in opsonization observed in sickle cell patients' 
serum is due to a defect in the alternate (properdin) pathway 
by which C-3 is directly fixed to antigen (Johnston et al., 
1973). They propose that synthesis of a component of the 
alternate pathway is depressed as a result-of either splenic 
or reticuloendothelial dysfunction. This dysfunction of 
the reticuloendothelial system in particular could be 
accounted for by the overload of crythrophagccytcsic 
and secondary iron overload resulting from the sickling 
of erythrocytes. More work remains to be done in this 
area to fully elucidate the cause of the increased 
susceptibility of the patient with sickle cell anemia 
to infection, particularly pneumococcal, on the cellular 
level. 
Another factor in susceptibility to infection may be 
impaired phagocyte function. Alveolar macrophages are highly 
dependent on aerobic glycolysis, much more so than other 
macrophages. Low oxygen tensions inhibit phagocytosis 
in alveolar macrophages (Green, 1968). In addition oxygen 
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is needed for the respiratory burst involved in the 
destruction of microorganisms by phagocytes (Babior, 1973). 
Thus low oxygen tensions both in the pulmonary capillary 
blood and in the alveoli (this will be further discussed 
later) may be a critical factor in impairing the function 
of alveolar macrophages in the sickle cell patient,, 
The two other hemoglobinopathies with similar clinical 
manifestations to SS disease are SC and S-Thalessemia, 
S-Thalessemia occurs in 0.3% of American blacks (Wintrobe, 1974 
In a population of 21 patients with documented S-Thalessemia, 
age range 17 to 53 years with a mean of 25,8 had documented 
pneumonia and 6 had more than one episode (Reynolds et al., 
1973). SC disease occurs in 0.8% of the American black 
population (Wintrobe, 1974). In her series of 24 patients 
with SC disease, Barrett-Connor observed that 10 patients 
had at least one hospitalization for infection (Barrett-Connor, 
1971-c). In this group, which had been followed for a 
total of 68 patient-years, there were 7 episodes of 
pneumonia, of which 3 were pneumococcal. In addition there 
were two episodes of pulmonary infarction documented by 
angiography. River et al. (1961) also reviewed the 
incidence of acute pulmonary disease in patients 
with SC hemoglobin. They observed a high incidence of chest 
pain, fever, cough, and leukocytosis, accompanied by 
infiltrate on chest x-ray. Thirty patients in their group 
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had a total of 46 episodes of acute pulmonary disease, 
which is a greater incidence than one would expect in 
a normal population. Although the data for S-Thalessemia 
and SC disease are more limited and more preliminary 
than for SS disease, it is certainly indicative of a 
higher than normal incidence of pulmonary disease in 
these two populations as well as in the SS population. 
Typically, then, pneumonia in patients with sickle 
cell disease tends to be characterized by a prolonged 
course. Frequently the response to antibiotics is 
poor, even when there is documentation that the antibiotic 
is the drug of choice. Multilobar involvement occurs 
often, and the pneumonia can progress, despite appropriate 
treatment, from one lobe to another during the course 
of hospitalization. Furthermore no pathogen can be 
isolated in many episodes of pulmonary disease in 
sicklers. Whether this pattern holds true for SC disease 
and S--Thalessemia has yet to be established. The 
preliminary data indicate that both groups have a 
higher incidence of pulmonary disease, which is more sever 
than in the normal population. There is some evidence to 
suggest that the increased incidence of pulmonary disease 




Embolization end Pulmonary Infarction 
The diagnostic dilemma in sicklers who present with 
acute pulmonary disease remains whether it has infection 
or infarction as its etiology. Reynolds et al. in 
reviewing radiologic findings in 22 sicklers found 4 
episodes of pulmonary infarction documented by lung scan 
(Reynolds et al. , 1973). In this same group of 22 patients 
they observed pneumonia in 8 patients with 6 patients 
having repeated episodes. The 4 cases of pulmonary 
infarction were accompanied by infiltrate on chest x-ray, 
transient right axis deviation on electrocardiogram, 
as well as moderate cardiomegaly. In another review 
of 89 patients followed for an unspecified number of 
years, there were 11 episodes of pulmonary infarction 
(method of diagnosis not given) versus 63 episodes of 
pneumonia (Karayalcin et al., 1975) . 
Certainly the incidence of pulmonary infarction is 
significantly increased over that in the general population. 
The difficulty of diagnosis remains. Repetitive, closely 
spaced bouts of pulmonary disease, which in the normal 
population would be interpreted as indicative of 
infarction, are not helpful in making the diagnosis in 
sickle cell patients. In Barrett-Connor1s study half 
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of the patients for v/hom it was proved that they did not 
have pulmonary infarction by lung scan,, angiography, 
or autopsy had multiple closely spaced episodes of 
pulmonary disease (Barrett-Connor, 1973). 
There are other signs and symptoms which can be 
helpful in diagnosis. Onset with a chill favors 
pneumonia (Barrett-Connors, 1973). Gross hemoptysis, 
considered in the normal population as suggestive of 
infarction, was not observed in any of Barrett-Connor's 
(1973) documented cases of pulmonary infarction. 
Furthermore Petch and Serjeant (1970) observed hemoptysis 
in 18 of 28 normal patients with acute lobar pneumonia and 
in only 1 of 28 sickle cell patients with "pneumonia". 
The simultaneous presence of thrombophlebitis and acute 
pulmonary disease in the normal population is considered 
highly suggestive of embolization and infarction. In 
sickle cell anemia thrombophlebitis is unnecessary. 
Infarction can follow fat or marrow embolization to the 
lung accompanying crisis, or can occur secondary to in situ 
sickling or thrombi of sickled cells. Thus a preceding or 
concurrent crisis would be expected to tend to favor 
infarction, and observations supporting this have been 
made (Barrett-Connor, 1973). 
Chest x-ray findings are not pathognomonic. Location 
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of an infiltrate in the lower lung fields, assymraetry if 
the infiltration is bilateral, segmental involvement, 
moderate elevation of the, diaphragm early in the course, 
and acute increased prominence of the pulmonary artery- 
all favor infarction (Reynolds, 1965). The five episodes 
of pulmonary infarction which Barrett-Connor reviewed 
indicated that older age, single lobe involvement, and 
associated clinical crisis are suggestive of the diagnosis 
of infarction (Barrett-Connor, 1971-a). Four of these 5 
patients had jaundice and serum bilirubins greater 
than 5 mg. per 100ml., while only 25% of patients with 
pneumonia had pain suggestive of crisis and only 2 of the 
patients had a similar increase in serum bilirubin. 
Several investigators have observed the presence of 
blister cells in the peripheral blood smears of patients 
with sickle cell anemia and pulmonary emboli and/or 
infarction (Barreras et al., 1968; Fetch and Serjeant, 1970 
Karaylacin et al. , 1972). These cells are characterized 
by the presence of "blebs" or "blisters" on their surfaces 
and are actually poikilocytes (Barreras et al., 1968). 
As the symptoms of the pulmonary episode resolved, the 
blister cells were noted to disappear from the peripheral 
blood by these investigators. Barreras et al. (1968) 
examined the peripheral blood smears of several sickle 
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cell patients with pneumonia, crisis, osteomyelitis, 
or other infections, and they found that none of these 
demonstrated blister cells. The examination of smears 
from patients with pulmonary emboli, but without sickle 
cell disease was inconclusive (Barreras et al., 1968). 
It remains to be seen if the observation of blister cells 
on the peripheral smear can foe a reliable diagnostic 
finding for pulmonary infarction in sickle cell disease. 
A key point is that G6PD deficiency will cause poikilocytes, 
or blister cells, and it is important to rule out this 
possible etiology for the presence of these cells in 
patients with pulmonary infarction. Before these 
observations on the presence of blister cells accompanying 
pulmonary emboli and infarction in sickle cell disease can be 
conclusive it is necessary that G6PD levels be demonstrated 
to be normal in the patients studied. 
In the sickle cell patient infarction of pulmonary 
tissue can occur through several mechanisms. Sickle 
crisis can be accompanied by embolization of both fat 
and marrow from bone marrow to the lungs (Shelley and 
Curtis, 1958). Thrombus can embolize to the lungs; 
thrombus formation may occur as a complication of 
pregnancy, frequently late in pregnancy or in the post¬ 
partum period. There are numerous case reports in the 
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literature of embolization, fat and marrow embolization 
(accompanying crisis) , and pulmonary infarction (often 
without any source of emboli) occurring in patients 
with SS, S-Thalessemia, and SC disease (Jewett, 1976; 
Bashior and Lindsay, 1975; Karayalcin et al. , 1972; 
Dunn and Haynes). The incidence of these complications 
has not been documented in pregnant women with sickle 
cell disease or the SC or S-Thalessemia variants. Nor 
is the incidence of marrow and fat embolization in 
association with crisis known. Clearly as these events 
can range from "silent" microemboli to multiple microemboli 
or massive emboli it would be difficult to document an 
estimate of incidence. However, it should be possible 
to document the frequency of major episodes of embolization 
and infarction in both the sickle cell population overall 
and in sickle cell patients who are pregnant. 
In addition to fat, marrow, and thrombus embolization 
there is also the possibility of in. situ sickling in the 
lungs. A precipitating stress might be a factor in this. 
For example, pregnancy further lowers the PO2 of venous 
blood returning to the lungs, and in a situation which is 
already precarious this might be enough to tip the balance 
and precipitate significant sickling within the lungs such 
that occlusion of pulmonary vasculature occurs. Or, a mild 

infection might precipitate sickling in the pulmonary 
vasculature when it otherwise might not have occurred,, 
and thus lead to infarction. Thus even if the initial 
event is a pneumonia, it can in theory be potentially 
complicated by pulmonary infarction. One can also postulate 
that once a sickling cycle is set off within the pulmonary 
vasculature this can lead to an acute episode of massive 
pulmonary hemorrhage and infarction. (1967; Rywlin et al. , 
1963; and Shelley and Curtis, 1958). Significantly many 
of these cases occurred in women who were pregnant or taking 
oral contraceptives. Frequently the hemoglobinopathy 
was unsuspected prior to the occurrence of pulmonary 
infarction. 
Diagnosis of pulmonary infarction in sickle cell 
patients remains difficult because of the somewhat confusing 
manifestations of pulmonary disease in these patients, and 
also because of the inherent risks in some diagnostically 
definitive procedures such as angiography, which can 
potentially precipitate sickling. An alternative is 
the lung scan, but this can be less satisfactory as 
its accuracy, depending on the medical center, varies, and 
there can be a high rate of false negatives, and or false 
positives. Also the smaller the emboli, the less likely 
that the scan will be positive. More will be said on 





There are a number of different findings on the chest 
radiographs of sickle cell patients. The occurence of 
cardiomegaly in virtually all patients with sickle ceil 
disease has been well documented (Henderson, 1950; 
Shubin et al., 1960; Reynolds, 1965; and Karayalcin 
et al., 1976). Pulmonary vascular markings tend to have 
increased prominence in all sickle patients, and this 
has been interpreted as due to increased cardiac output 
secondary to chronic anemia (Reynolds, 1965), In addition 
there is a range of findings in the lung fields, the 
frequency of which has not been established. Findings 
consistent with pulmonary hypertension and cor pulmonale 
occur. Karayalcin et al., (1976) reported engorgement 
of the hilar vessels in 29 of 125 patients (age range 
3 months to 50 years, mean 18 years) and a prominent 
pulmonary conus in 6 of the 125 patients. Zones of 
increased radio-lucency occur as well as transient 
patchy infiltrates. The latter have been described as, 
"faint, finely mottled and reticular in pattern", 
consistent with interstitial infiltrates (Reynolds, 1965). 
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It is these findings that Reynolds (1965) defines as 
sickle cell lung. In sickle cell patients at Parkland 
Memorial Hospital Reynolds estimated that less than 10% 
had radiographically what he defines as sickle cell 
lung disease. In addition he noted that in the population 
at Parkland he observed overt signs of pulmonary hypertension 
only in males over thirty (Reynolds, 1965). The significance 
of this last observation is not clear, and it may reflect 
some peculiarity of this particular patient population, 
particularly as no other reports have indicated that 
pulmonary hypertension is observed exclusively in males 
with sickle cell disease. 
Cardiac Function 
No examination of the effect of sickle cell disease 
on pulmonary function can ignore cardiovascular function. 
Anemia alone has cardiovascular manifestations. These 
usually occur with a hemoglobin of 7gm% or less, and 
include increased-cardiac output, decreased A-V 02 
difference, decreased peripheral resistance, and normal 
atrial pressure (Brannon et al., 1945; Varat, 1972). 
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Clinically patients have tachycardia, bounding arterial 
pulses, increased splitting of S2, a prominent S^, and 
systolic murmurs, which are usually most prominent in 
the second left intercostal space (Fowler, 1978). These 
findings are felt to be secondary to the increased flow 
resulting from increased blood volume and increased cardiac 
output. In sickle cell anemia signs of altered cardiac 
function, such as cardiomegaly, a systolic murmur, and 
increased cardiac output, are evident at much higher 
hemoglobins than in other anemias, and commonly occur with 
hemoglobins as high as S to 10 mg% (Varat, 1972) . 
During the 1350!s and early 1960's investigators performed 
several studies involving right heart catheterizations in 
asymptomatic sickle cell patients. Sproule et al. (1957) 
catheterized 6 adults with SS disease. None of these patients 
had known pulmonary disease, height et al. (1954) studied 
13 patients with SS disease ranging in age from 12 to 39. All 
13 had systolic murmurs and evidence of cardiac hypertrophy 
and/or dilatation on electrocardiogram or chest x-ray. 
Only two of these patients had a history of heart disease. 
The youngest was a 12 year old girl with a documented 
history of rheumatic heart 
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disease; the oldest patient was a 39 year old male who 
had been admitted in congestive failure. He had no 
evidence of primary pulmonary disease, but had the 
hemodynamic pattern of cor pulmonale. Brannon et al. 
(1945) examined txvo patients with sickle cell disease in 
their study of cardiac dynamics in chronic anemia. Hemo¬ 
globin electrophoresis results are not available on these 
two patients. It is assumed that they represent SS 
disease. The final study examined 7 children with SS 
disease ranging in age from 6 to 16 (Shubin et al., 1960). 
All 7 had some dyspnea and fatigue chronically. At least 
4 of the 7 had cardiac murmurs (not described) and at 
least 2 of the 7 (patients #2 and 5) had a history of 
pneumonia. 
The data from these studies is summarized in Table I 
along with normal values. Data is available on a total 
of twenty-eight patients, ranging in age from 6 to 39. 
8 of the patients are less than 15 years old. 5 patients 
are known to be in their 30*s, while the ages of 4 of 
the adults are not available. In this patient group there 
is one documented case of cor pulmonale. None of these 
patients is reported to have any form of pulmonary disease 
or any major medical disease other than sickle cell 
anemia, except for the two patients with rheumatic heart 
disease and cor pulmonale, already cited. 
Hemoglobin values ranged from 4.5 gra.% to 10.8% with 

Table I — Catheterization Data 
Cardiac Index 
Blood Vol, Arterial A-V 0?Dlfferenc 
Study Age/sex/Hgb Hgb RA RV PA//Ex. Wedge C.O. Room Air 100$ Op ml/Kg Op Sat. cc/t 
5.3 4.9 126 
Sproule 35/ss 4 25/3 20/8 8.0 5.4 4.3 121 
et al. ss 8 49/9 43/12 15.0 4.8 3.9 73 
(1957) ss 8 19/3 21/10 8.0 4.9 6.1 135 
ss 6 30/6 26/10 7.9 3.6 2.6 72 
ss 6 — -=> 4.9 7.7 
36/ss 2 17/0 18/8 4.5 
5.4 97.4 29.3 
Leight 12/F 9.7 2S//37 23 6.5 6.2 82.9 28.5 
et al. 39/H 7.7 31//44 7 10.2 5.4 86.9 27.3 
(1954) 27 10.8 20//26 14 9.3 6.4 89.3 19.2 
20 6.0 20//21 14 8.9 5.1 88.5 26.5 
19 5.8 17//28 13 6.9 5.9 91.1 28,5 
13 6.7 U//19 8 7.1 7.5 97.5 21.0 
17 8.3 17//19 13 14.5 6.1 93-4 30.4 
37 8.6 17//1B 9 10.3 15.9 96.1 19.4 
15 7.7 18//16 11 19.2 5.8 92.1 22.1 
25 8.4 17//23 12 9.2 5.9 • i .. • 94.2 24.3 
25 7.0 15 NA 9 10.1 7.5 J > 89.4 21.5 
19 7.0 15//18 10 10.6 5.5 93.4 22.1 
18 6.1 20//15 15 .8.5 . 
7.2 86.8 
Shubin 6/F/SS 8.4 7/4 35/5 28/12 7/4 8.2 90.! 5 76.5 
et al. 8/F/SS 7.4 8/5 35/6- 27/11 7.2 86.! 3 79.3 
(I960) 9/F/SS 6.5 8/4 30/6 27/12 11/6 4.6 67.1 > 88.5 
12/F/SS 7.0 5/2 27/33 25/13 12/6 11.7 119.! 3 80.2 
13/F/SS 6.3 5/3 23/3 22/10 8.5 109.5 78.8 
10/M/SS 7.4 5/1 30/4 28/9 10/4 3.8 91.4 89.0 
16/F/SS 9.5 7/2 32/2 29/8 10/5 
6.2 
Brannon 17/F 4.5 2.6 10.3 7.6 
et al. 35/m 6.4 1.0 13.1 
(1945) 
Key to symbols: hs?b-heraoglovlu, where not listed .unknown. RA- rlvht 
atrial pressure, mean or svstollc/dlastolio'RV-right ventricle pres¬ 
sure, systollc/dlastollc)PA//Ex.- pulmonary artery pressure either 
systollc/diastolle or mean at rest//mean with exercise) wedge- 
pulmonary artery wedge pressure) C.O.-cardiac outuut, L./min.j 
Arterial 02 saturation In Dercents>A-V O2, arterial-venous Og 
difference) All pressures In mmHg, where necessary values have been 
converted to mmHg. 
Normal Values: 
Schlant(1978) RA 2-14/-2 - +6: RV 15-28/0-8: PA 15-28/'5-l6, mean 
10 - 22) Wedge 9-23/1-12, mean 6-15) Arterial 0? Sat. 94-100$) 
A-V O2 difference 30 - 48. 
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a mean of 6.9% in this patient group. Cardiac' output 
was increased markedly in all of the patients compared 
with a normal of 5 to 6 L/min. The cardiac index was 
also strikingly elevated in all patients except for one 
16 year old female in Shubin et al.’s study who had a 
cardiac index of 3.8 L/min.f which is upper normal. 
Blood volume per kilogram of body weight was assessed 
in two studies (Sproule et al., 1957; Shubin et al., 1960) . 
The values are notably elevated in all except one patient, 
when the values are compared with the normal values of 
69 ml/kg for males and 65 ml/kg for females. 
Right heart catheterization showed normal right 
atrial pressures (Sproule et al., 1957; Shubin et al., 
1960; Brannon et al., 1945). Right ventricular pressures 
were elevated in 2 out of 6 patients studied by Sproule 
et al. (1957) and in 5 out of 7 patients in Shubin's 
study. Two of the patients in the latter study had known 
heart disease as mentioned previously (rheumatic heart 
disease and cor pulmonale). The pulmonary artery pres¬ 
sures measured in these two studies were markedly 
elevated in 1 of the 5 patients and were upper normal in 
a second patient in the first study. Both of these 
patients had elevated right ventricular pressures. Pul¬ 
monary artery pressure was elevated slightly in one 
patient in Shubin's study and top normal in the remaining 
6 patients. Moser et al. reported an increased mean 
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pulmonary artery pressure in 3 of 10 patients in another 
study (1960) . Leight et al. (1954) measured pulmonary 
artery pressures at rest and with exercise in their 
patients. At rest pulmonary artery pressure has a mean 
of 12 mm Hg with no significant change in this value from 
4 to 7 0 years of age (Blount and Grover, 1978) . Pulmonary 
artery pressure should remain the same or decrease with 
exercise (Luchsinger et al., 1957). An exception to 
this has been observed in normal supine patients with 
severe exercise on a bicycle ergometer such that cardiac 
output is tripled. Under these conditions pulmonary 
artery pressure has been observed to increase as much as 
15 mm Hg (Blount and Grover, 1978). The decrease in 
pulmonary artery pressure with moderate exercise reflects 
vasodilatation and perfusion of portions of the capillary 
bed which are either underperfused or not perfused at rest. 
Leight et al. found that mean pulmonary artery pressures 
were normal to top normal at rest in all but two of the 
patients, who had rheumatic heart disease or cor pulmonale. 
With exercise the pulmonary artery pressure increased in 
seven of the thirteen patients. Wedge pressures in these 
patients were normal except for a markedly elevated wedge- 
pressure in the patient with rheumatic heart disease. 
Other investigators have also observed an abnormal increase 
in pulmonary artery pressure with moderate exercise in 
patients with SS disease (Moser et al., i960). 
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Echocardiographic studies on 23 asymptomatic patients 
with SS disease and a mean age of 29.5 years (range 16 to 
53) showed normal mean right ventricular dimensions for 
the group when compared with nine healthy controls (Gerry 
et al., 1976). However, three of the sickle cell patients 
did have elevated right ventricular dimensions. No para¬ 
doxical septal motion was noted. When the patient group 
was split into two subpopulations on the basis of age, 
group I (mean age 22.1) versus group II (mean age 43.5), 
no significant difference was noted between the two groups 
/ 
for the mean right ventricular dimensions. Examination 
of the left side of the heart showed increased atrial and 
ventricular cavity size as well as increased left ventri¬ 
cular mass and stroke volume. Gerry and his coworkers 
concluded that the findings could be accounted for by the 
chronic volume overload secondary to anemia, and that the 
lack of significant difference between younger and older 
patients (again comparing the two subgroups) indicated 
that this volume overload was well tolerated by the left 
ventricle. 
The question is, does progressive pulmonary hyper¬ 
tension and cor pulmonale occur in at least a subpopulation 
of those with sickle cell anemia. Of the 28 patients 
catheterized as part of the studies discussed here, only 
one, a 39 year old male, had cor pulmonale. Only 5 of 
the patients in this group are known to have been in their 
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thirties. The majority are much younger. It would be 
logical to reason that pulmonary hypertension might arise 
both from microemboli of sickled erythrocytes,, fat, and 
marrow, and from in situ sickling in the lungs. All of 
these might be expected to accompany sickle crises. The 
result of these phenomena would be occlusion of micro¬ 
arteries in the lung, and would lead to a reduction in the 
cross-sectional area of the pulmonary vasculature. The 
importance of this cross-sectional area will be discussed 
later. 
The life course of sickle cell anemia is punctuated 
by crises of varying clinical severity and varying fre¬ 
quency. Both aspects of the disease differ from patient 
to patient; some patients have severe disease diagnosed 
early in childhood; other patients have seemingly mild 
disease not diagnosed until adulthood, and even then only 
as an incidental finding in the course of an examination 
for other reasons. But, given the chronic pattern of 
sickle cell disease, one would expect to see pulmonary 
hypertension more frequently as the age of the patient 
population increases, and also more frequently in those 
with more severe disease, as measured by frequency and 
severity of crises. Yet in the single echocardiographic 
study done, only three patients had increased right 
ventricular dimensions, and no significant difference was 
noted between two patient subpopulations divided by age. 
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However, enlargement of the right ventricle would be 
expected to occur late in the course of pulmonary hyper¬ 
tension so one would not anticipate that right ventricular 
enlargement would be present in a large percentage of 
patients. Furthermore, the incidence would also vary 
with the severity of the sickle cell disease, and no 
information on this was provided in this study. Less 
severe sickle cell disease tends to favor longevity. And, 
lastly, no information is provided on the incidence of 
acute pulmonary episodes in this patient population, 
which as will be discussed later, is a significant factor. 
Although only one of the 28 cases who underwent 
cardiac catheterization had cor pulmonale, 5 additional 
cases showed an abnormal increase in pulmonary artery 
pressure with moderate exercise. A similar observation 
was made in 3 of 10 patients in another study (Moser et 
al., 1960). This indicates a reduced pulmonary capillary 
bed reserve in these patients (Luchsinger et al., 1957). 
The pulmonary vascular bed normally possesses considerable 
reserve; a significant increase in pulmonary artery 
pressure does not occur until the total cross-sectional 
area of this vascular bed has been reduced by more than 
50% (Blount and Grover, 1978). 
Blount and Grover (1978) in their discussion of 
pulmonary hypertension list three etiologies: (1) in¬ 
creased pulmonary capillary or left atrial pressure, 
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(2) reduced cross-sectional area of the total pulmonary 
•vascular bed, (3) significantly increased pulmonary 
arterial blood flow. They also cite pulmonary blood 
volume, bJood viscosity, intrapulmonary pressure, and 
mtrathoracic pressure as possibly contributing a minor 
role in the development of pulmonary hypertension. The 
daca indicate that the patients examined in the studies 
discussed here had normal pulmonary capillary and left 
atrial pressures as reflected by normal wedge pressures. 
Recurrent microemboli occur in sickle cell patients accom¬ 
panying crises, and in situ sickling in the lung is a 
possible second mechanism of vascular occlusion. Both 
of these phenomena, microemboli and in situ sickling, can 
lead to occlusion of microarterioles and a reduction in 
the cross-sectional area of the pulmonary vasculature. 
All of these patients (who underwent cardiac catheter¬ 
ization) had markedly increased cardiac outputs. In the 
absence of right to left shunting this increased cardiac 
output must also be reflected in an increased blood flow 
to the lungs. Significant increases in pulmonary blood 
flow alone, as seen with major shunts such as occur with 
eft to light ^.hunting in intraseptal defects can cause 
pulmonary hypertension. The combination of increased 
pulmonary blood flow (of lesser magnitude than that seen 
with a major shunt) with a somewhat decreased pulmonary 
vascular bed cross-sectional area can result in an increase 
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in pulmonary resistance and in pulmonary hypertension 
(Blount and Grover, 1973). As already discussed, a 
decrease in the pulmonary vascular bed is a potential 
long teim complication of sickle cell disease and the 
likelihood of its occurence can be anticipated to be a 
function of the severity of the sickle cell disease in 
terms of frequency of crises. Also, it can be deduced 
that pulmonary blood flow in these patients is increased, 
as their cardiac outputs are increased. This is supported 
by two studies demonstrating an increase in the volume 
of pulmonary capillary blood ( Femi-Pearse et al., 1970; 
Miller and Serjeant, 1971). The magnitude of the increase 
in pulmonary blood flow would depend upon the severity of 
the anemia, which would again reflect the severity of 
the sickle cell disease. So, if pulmonary hypertension 
and cor pulmonale are long term complications of sickle 
cell disease, one would anticipate that this complication 
would supervene in the older sickler with more severe 
disease. The only catch to this is that these patients 
most likely succumb at an early age to other complications 
of sickle cell disease. 
Pulmonary Function 
Several investigators have done studies examining 

pulmonary function in patients with sickle cell disease. 
Femi-Pearse et al. (1970) studied 6 patients with SS diseas 
ranging in age from 17 to 31. Bromberg and Jensen (1967) 
did pulmonary function tests on 10 patients with SS disease 
ranging in age from 16 to 49. Young’s studies involved 
9 patients with SS disease ranging in age from 16 to 49 
(Young et al., 1976). The final study in which detailed 
tables of the findings are given is that of Miller and 
Serjeant (1971). They compared two groups of SS patients. 
Thirteen had a history of pulmonary "episodes," which they 
defined as pneumonia, pleurisy, hemoptysis, and acute 
chest illness of at least one week's duration, or isolated 
attacks of wheezes and breathlessness in a nonasthmatic.. 
In addition, they broke their patients down as to smokers 
and nonsmokers, and compared, these two groups as well. 
The data from these four studies are summarized in 'Table 
II along with normal values. For many pulmonary function 
tests normal values are determined by parameters specific 
for each patient, such as height, weight, and age. There¬ 
fore, where investigators have provided data as to the 
predicted value for a given test for a given patient, or 
for the percent of the predicted value, these data are 
listed in the table. 
Total lung capacity was consistently less than the 
predicted value for all but one patient out of these four 
studies. Others have also observed a consistent reduction 
in total lung capacity (Diggs, 1969). Vital capacity is 

Table II —Pulmonary Function Test Data 
S tud v acre/sex/hetb VC (L) VC/VPC TLC £Pred, RV/TLC FRC £Pr FVC £Pred. FEVl FEVi/FVC FEFo e .05 Vmax Dt. Vc(ml) DM AaP0? SaO?$ Shunt(calculated) 
Bromberg 41/F/SS 2.23 75 
„ . . 13.8 7 97 4.8 
& Jensen 17/F/SS 2.08 60 - - - 6.0 3? 80 19.3 
(196?) 21/F/SS 2.26 68 2.72 69 17 8,6 3? 86 
17.4 
21/H/SS 3.70 81 5.13 94 28 12.7 25 
86 14.3 
39/K/SS 3.09 76 4.74 94 35 10.0 20 
90 2.8 
16/F/SS 2.62 76 3.39 83 23 8.2 20 
90 2.5 
49/F/SS 2.73 70 - • 87 
20/F/SS 3.50 108 _ 10.6 27 
GO 4.0 
17/M/SS 2.83 6? „ 14.0 28 79.5 7 • 9 
16/F/SS .3-13., 90 - - - „ „JJL- 
9^.5 13.2 
Young et 26/M/S3 4.33 86 32 3.96 94 4.10 82 75 2.60 10.1 15 
al.(1976) 49/M/SS 2.72 66 22 2.31 71 2,66 64 81 2.52 9.6 24 
38/F/SS 2.58 74 22 1.66 64 2.57 74 87 4.18 6.9 15 
37/M/SS 4.61 85 25 2.84 71 ^.53 83 80 ^•55 8.2 19 
24/P/SS 2.13 57 ~ ' \ 28 1.77 53 2.08 55 88 2.92 8.0 12 
23/H/SS 3.05 65 27 2.81 85 2.96 63 88 3.50 5?3 21 
28/K/SS 3.46 64 41 3.44 74 3.57 66 63 1.45 5.5 17 
21/F/SS 1.92 52 - - - 1.92 52 80 1.90 = 18 
44/K/SS 3.18 69 _ __Is 100 3.18 . 69 80 3.20 - 21 
Femi- 18/M/SS 























23 70 47 
20 89 39 
22 69 48 
32 92 66 
20 77 41 
27 95 4*5 
values listed here are means S.D. All subjects are SS. mean 24(2578? (6? )w48 (65 ) 
Miller & 16 males 3.39 4.9 32 2.74 3.13 2.55 81.9 0976 4377 
Serjeant 28,2-t/-8.7 +/-.7 3 +/-.80 +/-8 3.14 81.7 69.6 63.O 
(1971) Predicted ^.15 5.61 26+/-3 3.27 p <C .001 n.s . p 1 .01 p < .001 
values p^ .001 D < .001 p <1.001 p £-.01 
3.80 2.10 84,2 78.0 29.0 
9 Females 2.44 3.94 38 2.34 p<.ooi 2.37 81.5 61.0 44.7 
27.8&/-10.9 +/-.24 +/“ • 5 +/-7 n.s. n.s. p 1 .05 pt .001 
Predicted 2.96 4.42 32 2.64 
values PC .001 P c .01 p <.01 n.s. 2.47 97.5 36.8 
60.9 
K,APE(8) 2.96 p < .001 
Predicted 4.06 
P ^.001 2.88 81.8 55.2 
M,NP(8) 3.82 n.s. 65.3 
Predicted 4.25 n.s. 
P < .05 
F,APE(5) 2.41 81.0 28.6 
Predicted 3.04 44.7 
p < .001 p L .001 
74.3 29.4 
F,NP(4) 2.48 n.s. 44.6 
n.s. p < .001 
„ -, - ^-■**■=*■•*'*■ ^ . *icu.=iJi5ui«,su,iiy=resxau9i volume; rHCa 
Functional residual capacity;FVC=forced vital capctty;FEVi= foEced 
expiration In 1 secona;FEFsvolume of mid-expiratory flow; Vmass= 
peak expiration;Di“GO' diffusing capacity; Vc= volume of pulmonar 
capillary blood(ml); Dgppulmonary membrane diffusing capacity; 
symbols(cont,)AaP02= alveolar-arterial P02 difference; Sa02&= 
percent arterial oxygen saturation;M,APE= males with a history 
of acute pulmonary episodes, eight In all;M,NP= males with no 
history of acute pulmonary episodesj five In all; F,APE & 
F,NP denote the same for females; n.s.= not significant. 
mean values for 30 normals measured by Feml-Fearse et al.(19?C 
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reduced as well. Miller and Serjeant (1971) found vital 
capacity to be significantly reduced below that predicted 
for both males and females (p < .001). However, when they 
broke their patient population down into four subgroups 
(subjects with and without a history of acute pulmonary 
disease and each of these groups divided by sex), they 
found vital capacity to be significantly reduced in all 
groupsr except in females without any history of acute 
pulmonary episodes. 
Residual volumes as a percent of total lung capacity 
were significantly increased in both males (p < .001) and 
females (p < .01) in Miller and Serjeant's study (1971). 
Other reports of residual volume as a percent of total 
lung capacity do not provide predicted values. The values 
reported (as listed in Table II) are within the range of 
normal with the exception of four subjects who show an 
increased residual volume. 
Only two of the studies examined additional parameters 
of ventilatory capacity. Functional residual capacity was 
found to be significantly (p < .01) less than the predicted 
value for males, but for females there was no significant 
difference between predicted and measured values (Miller 
and Serjeant, 1971). In the other study functional 
residual capacity was reduced in all but one of the 
patients (Young et al., 1976). Forced vital capacity is 
markedly reduced below the predicted value in both sets 
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of patients studied (Young et al,, 1976; Miller and 
Serjeant, 1971) . Only Miller and Serjeant measured the 
forced expiratory volume in one second (FEV^). They 
found it to be significantly decreased in males (p < „001), 
but to not be significantly decreased in females. They 
also calculated FEV^/FVC and found no significant dif¬ 
ference between the predicted value and that measured 
(Miller and Serjeant, 1971). This concurs with the 
findings of Young et al.. (1976) which demonstrated 
FEV^/FVC to be normal in all but one subject. Young et 
al. also measured the FEF,^ which reflects the volume 
of air expired during the midperiod of expiration. In 2 
of 9 patients it was increased over the expected, while 
in the other seven it was reduced. In the seven patients 
in whom they measured V (peak flow during forced expi- 
ration) they found the values to be normal to elevated 
in four and reduced in three. 
So, in summary, studies of ventilatory capacity show 
a reduced vital capacity and total lung volume. Residual 
volume is normal to increased. Functional residual capa¬ 
city is normal to reduced. Forced vital capacity is also 
reduced. FEV, is normal to reduced, and FEV.,/FVC is 
normal. This pattern is one that is more consistent with 
restrictive disease rather than obstructive disease. 
Investigators have examined airway function and 
ventilation distribution in sickle cell patients. Young 
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et al. (1976) using the nitrogen delta test found abnormal 
gas diffusion in only 1 of 5 SS patients. None of the 
6 patients examined by Femi-Pearse and his coworkers 
(1970) using a helium mixing index demonstrated abnor¬ 
mality in gas distribution, nor did any of these patients 
have evidence of airway obstruction. Young et ai. (1976) 
also found normal small airways in 5 patients using the 
closing volume test. Assessment of large airway function 
wTith a body plethysmograph showed evidence of obstructive 
disease in only 1 of 9 patients (Young et al., 1976). The 
numbers of patients examined in these two studies is 
small, and further studies confirming these results would 
be useful. The findings of these two sets of investigators 
are indicative of normal airway function and normal venti¬ 
lation distribution in these patients. 
Measurements of parameters of gas exchange in the 
lung showed D (pulmonary membrane diffusing capacity) to 
be reduced. Interestingly, Miller and Serjeant (1971) 
found that D was reduced significantly in those subjects 
with a history of acute pulmonary episodes, both male and 
female, but was not reduced significantly in those 
subjects with no history of acute pulmonary episodes. 
Furthermore, they found that D was reduced in nonsmokers, 
but not in smokers. They interpreted this as reflecting 
either that carbonmonoxyhemoglobin S formation might be 
protective, or that those with more severe sickle cell 
' 
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disease and poorer pulmonary function would self-select 
and choose not to smoke. 
The carbon monoxide diffusing capacity (D..CO) in 
sickle ceil patients is also reduced. Although ail 
investigators found D CO to be reduced, only Femi-Pearse 
and his coworkers interpreted the D CO as high relative 
to the anemic state of these patients. However, other 
investigators interpreted DCO as reduced, even after 
taking into account the patients' anemia. None of the 
investigators applied the formula of Dinakara and his 
coworkers (1970) which corrects D^CO for the degree of 
anemia present. Anemia alone, will give a falsely reduced 
D CO which reflects the anemia, and not pulmonary function. 
Arterial blood gases in sickle ceil patients show 
a reduced arterial PO^ as well as a reduced oxygen satu¬ 
ration (height et al., 1954; Shubin et al., 1960; Brom¬ 
berg and Jensen, 1967)„ The alveolar-arterial oxygen 
gradient (AaPO,.,) is increased in sickle cell subjects 
(Fowler et al, 1957; Moser et al., 1960; Jensen and 
Bromberg, 1967; Diggs, 1969 ; and Miller et al., 1973) . 
With exercise the AaPO^ gradient increases in sickle 
subjects (Miller et al., 1973; Moser et al., 1960). 
Miller et al. (1973) found , which measures physio¬ 
logic dead space, failed to drop below resting values 
upon exercise in 10 of 20 subjects. In addition they 
found that in 9 of 10 subjects thirty minutes of breathing 
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100% oxygen failed to raise the PaO? above 500 ram Hg. 
This result concurs with that of Sproule and his coworkers 
(1957) who found an average Aa gradient of 165.4 ram Hg 
while breathing 100% oxygen in those patients who had 
arterial oxygen desaturation on room air. Bromberg and 
Jensen (1967) also found the arterial PO? to be reduced 
on 100% oxygen with 4 of 9 patients failing to reach a 
PaO^ of 500 ram Hg. Sproule et al« (1957) calculated an 
average shunt in their patients of 11.96%, while Bromberg 
and Jensen (1967) calculated shunts ranging from 2.5 to 
13.2% (see Table II for data). The failure of hypoxemia 
to disappear on breathing 100% oxygen indicates shunting 
(West, 1974) . All of these investigators interpreted 
these findings as consistent with venous shunts and with 
pulmonary thromboembolism. 
There have been mixed reports concerning the oxy¬ 
hemoglobin dissociation curve in sickle cell disease. 
Diggs (1969) observed a marked rightward shift in the 
oxygen dissociation curve which confirmed the observations 
of others (Becklacke et al., 1955; Fowler et ai., 1957). 
However, Young et al. (1976) found no abnormality in 
the oxyhemoglobin dissociation curve. There are several 
possibilities which could account for the discrepancy 
between Young's data and that of other studies. High 
levels of hemoglobin F (10% or more) can shift the oxy¬ 
hemoglobin curve towards normal (Milner, 1974), and this 
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could possibly account for at least some of the difference 
If the subjects in Young's study had high levels of hemo¬ 
globin F this would have shifted the dissociation curve. 
The electrophoresis patterns of the subjects, however, 
were not reported beyond that they were S3. Also, the 
technique they used in assessing the saturation values 
they obtained may have contributed to their finding no 
difference from normal. Rather than measuring oxygen 
saturations of blood from normal and sickle subjects at 
various PaC^ values, and then using this data to derive 
a normal curve and a sickle curve, they made a single 
determination of the oxygen saturation of the bleed of 
each of the nine subjects in their sample. They then 
applied this data to a standard curve and observed that 
their data more or less fit the normal curve. The impre¬ 
cision inherent in this method and the lack of normal 
controls performed in their own laboratory to standardize 
their technique could have caused them to obtain different 
results than all the other investigators. 
The studies which have been done on sickle cell 
patients indicate three possible abnormalities in pul¬ 
monary function: (1) restrictive disease, as evidenced 
by measurements of ventilation capacity, (2) diffusion 
deficiency as evidenced by a reduced D , a reduced . 
m L 
and arterial oxygen unsaturation, and (3) venous shunting 
as evidenced by a persistent alveolar-arterial 0.., gradient 
■ 
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Repeated bouts of pneumonia, while breathing 10G% Cp. 
embolism, and infarction can potentially lead to scarring 
which would result in restrictive type disease. Micro¬ 
emboli to small distal arteries in the lung are more likely 
to result in intralveolar hemorrhage and pulmonary infarc¬ 
tion than major emboli (Dalen et al., 1977). Multiple 
episodes of pneumonia, embolism, alveolar hemorrhage, and 
infarction can result in scarring and thickening of the 
alveolar-capillary membrane. This would impair gas 
exchange. Furthermore, increased pulmonary blood flow, 
particularly across a reduced vascular bed, can result in 
a reduced transit time across the pulmonary capillaries, 
and thus reduced contact with the alveolus. In the normal 
lung only one third of the transit time is necessary for 
equilibration between alveolar gas and the blood (West, 
1977). If this transit time is reduced as a result of 
increasing the velocity of the blood, the net result could 
be impairment of gas exchange. It is clear that the 
critical value would be a tripling of the rate of blood 
flow, which is a significant increase. Nonetheless, the 
combination of an increase in blood velocity with scarring 
and thickening of the alveolar membrane could result in 
impaired gas exchange at lower blood velocities. The 
third abnormality, venous shunting, could arise as a result 
of gross V/Q mismatch, again as a result of infarction and 
scarring. The possibility of bronchopulmonary anastomoses 
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has been raised by finding such anastomoses in the 
autopsy of one sickle cell patient (Heath and Thompson, 
1969). Such anastomoses might contribute to shunting, 
but the observation has yet to be confirmed. 
A diffusion defect across the alveolar-capillary 
membrane can give rise to hypoxemia in the pulmonary- 
capillary. The response of the pulmonary capillary to 
hypoxemia in a given area is vasoconstriction in that 
area. This hypoxic vasoconstriction would decrease the 
pulmonary vasculature cross-sectional area. Potentially 
this can result in increased pulmonary pressure if the 
cross-sectional area is already critically reduced. It 
is possible that exercise by increasing the cardiac output 
and blood velocity decreases the transit time in the 
pulmonary capillaries resulting in hypoxemia in a portion 
of the pulmonary vasculature. This would then cause 
vasoconstriction and could cause increased pulmonary pres¬ 
sure if the pulmonary vascular bed is already reduced. 
This could account for the increase in pulmonary artery 
pressure observed in a number of sickle cell patients with 
moderate exercise. 
The onset of pulmonary disease in sickle cell patients 
can be anticipated as being insidious. Rather than major 
embolic episodes resulting in pulmonary impairment, 
multiple episodes of small, frequently "silent"' or unnoted 
microembolizations and in situ sickling accompanying crisis 

result in a gradual impairment of pulmonary function. 
More than 50% of the pulmonary vascular bed must be 
obliterated before pulmonary hypertension will be evident. 
Thus pulmonary disease would evolve over a long period 
of time, and would be expected to be more likely to occur 
in those with more severe sickle cell disease and to be 
most often evident in the older population of sicklers. 
However, as mentioned previously, those most likely to 
survive into their thirties and forties are those with 
less severe disease. Nonetheless there have been a 
number of reports of cor pulmonale in sickle cell patients 
in the literature, and this would represent the end-stage 
of pulmonary disease in sicklers (Yater and Hansmann, 
1936; Moser and Shea, 1957). 
In addition to the development of pulmonary disease 
over the chronic course of sickle cell disease, an acute 
counterpart to this process is also possible. Two 
mechanisms, embolization and in. situ pulmonary sickling, 
can potentially cause severe acute disease of the lung. 
Both can result in alveolar hemorrhage, infarction, and 
vasoconstriction. In turn an increase in pulmonary 
artery pressure can occur. For reasons already detailed 
a reduction in the oxygenation of the blood can occur. 
This can set up more vasoconstriction. Also this will 
potentiate both sickling in the pulmonary vasculature and 
elsewhere as well. Furthermore low oxygen tensions 
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impair macrophage function and this predisposes the 
patient to pulmonary infection. Pneumonia will further 
reduce lung function and oxygenation of the blood. Thus 
a vicious cycle can be set up which potentially leads to 
pulmonary failure. 
Pathology 
Several reports of pathological findings in the lungs 
of patients with sickle cell disease have appeared in the 
literature. Yater and Hansmann (1936) reported two cases 
of cor pulmonale in patients with sickle cell disease. One 
of these was acute in. onset. Autopsy of the first showed 
many thrombi in small and medium sized arteries in differ¬ 
ent stages of organization. In addition arteriole thick¬ 
ening and hyalinization were present. The lungs were 
edematous with bleeding into the alveoli of the lower 
lobes. No gross infarct was evident. Autopsy of the 
second patient showed cardiac dilatation, hepatomegaly, 
and emphysematous lungs. Microscopic examination was not 
performed. 
In a review of the autopsy findings of 72 patients 
with sickle cell disease, 62 of whom had SS, Diggs 
reported finding sickling in pulmonary blood vessels, 
proceinaceous material in alveoli, emboli in pulmonary 
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arteries, serofibrinous pleural effusions, and pleural 
adhesions (Diggs, 1969). Emboli consisted of thrombi, 
sickled erythrocytes, fat, marrow, and bone, Emboli 
and infarcts were observed only in one of 32 children less 
than 10 years of age. Fresh and organized pulmonary emboli 
were present in 18 of 30 patients, and gross infarcts were 
present in 12. 
Oppenheimer and Esterly (1971) reviewing autopsies on 
36 patients with sickle cell anemia ranging in age from 2 
months to 34 years demonstrated similar findings. Approx¬ 
imately two thirds of the patients had thromboembo]i in 
various degrees of organization. Pulmonary edema was 
present in 23 out of 36, and 9 showed dilatation of 
interstitial spaces and pulmonary lymphatics. In 17 out 
of 36 pulmonary infection was present. Oppenheimer and 
Esterly noted proliferation of the arterial intima in 8 
of the cases. It was not extensive and was associated 
with pulmonary hypertension in only one female with cor 
pulmonale. Over one fifth of the cases had intimal pro¬ 
liferation and pulmonary infarcts. Similar changes were 
observed in 6 patients with SC disease. In addition 
they reported observing hyperplasia of the pulmonary 
lymphoid tissue in nearly all of the cases. 
Both Diggs and Oppenheimer and Esterly felt that the 
incidence of thromboemboli in the lungs increased 
significantly with age. With thrombi and sickling in the 
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lungs of sickle cell patients, there is always the 
difficulty of distingue si ng what occurred pre-mortem 
from what occurred post-mortem. However, the thrombo- 
emboli reported by these investigators showed various 
stages of organization, indicating that they were not the 
result of port-mortem thrombosis and sickling. 
There has been one case report of bronchopulmonary 
anastomoses in a 28 year old male with SC disease (Heath 
and Thompson, 1969). This patient died suddenly, and 
autopsy showed that the right ventricle was at the upper 
limits of normal in size. The left ventricle was normal, 
and no coronary fibrosis was present. Examination of the 
lungs revealed widespread occlusion of the elastic 
pulmonary arteries by thrombi in various stages of organi 
zation. Atrophy of the media under organized thrombi was 
present in many areas with loss of musculoelastic tissue 
and a marked decrease in medial thickness. In these 
areas Heath and Thompson reported finding disruption of 
the elastic fibrils and small capillaries communicating 
with branches of prominent bronchial arteries. These 
bronchopulmonary anastomoses were usually less than 100 u 
in diameter. There have been no other reports of broncho 
pulmonary anastomoses in sickle cell patients, and Oppen- 
heimer and Esterly (1971) specifically note the absence 
of any such anastomoses in any of the cases they examined 
The reports of pathological findings in the lungs of 
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patients with sickle cell anemia are limited. The question 
is whether these few reports present data that would 
support or exclude the hypothesized progressive course 
marked by multiple episodes of microemboli,, often silent, 
leading to pulmonary scarring, reduction in the size of 
the pulmonary vascular bed, and eventually to pulmonary 
hypertension and cor pulmonale. 
Pathologically there are three types of pulmonary 
hypertension: (1) plexogenic pulmonary arteriopathy, 
(2) recurrent pulmonary thromboembolism, and (3) veno- 
occlusive disease (Edwards and Edwards, 1977). It is 
the second type that we would anticipate to find patho¬ 
logical changes for. Recurrent pulmonary thromboembolism 
is characterized pathologically by thromboemboli in the 
microscopic arteries (Edwards and Edwards, 19 7 7) . These 
thrombi are either embolic in nature or develop in situ 
in the lungs. In addition with recurrent thromboembolism 
secondary changes occur at the precapillary level with 
medial hypertrophy of the muscular pulmonary arteries 
(Edwards and Edwards, 1977). The alveolar capillaries and 
veins are normal. 
The pulmonary vasculature of Yater and Hansmann's 
patient with chronic cor pulmonale showed arteriole 
thickening, but cor pulmonale was already established in 
this patient, 6 of the 12 adults with SS disease in 
Oppenheimer and Esterly's study showed intimal prolifera- 
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tion. Only 2 of 12 children between the ages of 3 and 14 
had similar findings, and intimal proliferation was not 
observed in any of the 12 children with SS disease under 
3 years of age. This is suggestive of a progressive 
change in the pulmonary arterioles with age resulting in 
increased intimal proliferation. They observed intimal 
rather than medial thickening. However, this is only 
one report. All of the investigators reported observing 
thromboemboli in the pulmonary vasculature in many of the 
cases. The frequency of this finding tended to increase 
with age. In the few reports with microscopic examination 
of the lungs, there was no report of medial hypertrophy. 
The pathology reported by these various investigators 
definitely demonstrates thromboembolism as a significant 
occurence. It is not possible to determine from these 
few reports the frequency of changes consistent with 
pulmonary hypertension and cor pulmonale. It is clear tha 
a more extensive review of the pathology of the lungs of 
patients with sickle cell disease is needed in order to 
better define the pathological changes which occur. 
< 
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The studies which have been done suggest a chronic, 
insidious course marked by repeated pulmonary infections, 
microemboli, and in situ sickling. This can lead to 
scarring and fibrosis in the lung and reduction of the 
pulmonary vascular bed. Increased cardiac output together 
with a reduction in the cross-sectional area of the pul- 
raoanry vascular bed can result in pulmonary hypertension 
and eventually cor pulmonale. Cor pulmonale may not be 
seen frequently because those one would postulate as being 
most likely to develop it, those with the most severe 
sickle cell disease, are more likely to succumb early to 
other complications of their disease. Evidence indicates 
an impaired immune system and possibly impair merit of 
alveolar macrophage function. Impairment of alveolar 
macrophage function has yet to be demonstrated in. vivo, 
but it can be suspected on the basis of reduced oxygen 
tensions and the necessity for high oxygen tensions for 
alveolar macrophage function in microbial phagocytosis. 
Infarction and pneumonia are both important pulmonary 
complications of sickle cell anemia. The prolonged course 
for pneumonia observed in these patients suggest that 
these episodes might be complicated by in situ sickling, 
pulmonary hemorrhage, and/or infarction. 
These patients show cardiomegaly and other signs of 

chronic anemia such as tachycardia. Cardiac catheteri¬ 
zation studies are suggestive of increased pulmonary 
pressure and reduction in the pulmonary vascular bed. 
Pulmonary function studies which have been reported are 
suggestive of restrictive disease and of venous shunting. 
Data also indicate a diffusion defect, but more accurate 
studies of carbon monoxide diffusion which correct for 
the patients* anemia need to be done. There is some 
evidence of an increased As. oxygen gradient as well, 
which, indicates impairment of gas exchange. More infor¬ 
mation is needed on pulmonary function including confir¬ 
mation of the observations which have been made. Data 
from pulmonary function studies done on the Yale-New Haven 
population of sicklers will be presented in the second 
section of this paper. 
Pathological reports on sickle cell patients are 
very limited. Pulmonary microemboli are present very 
frequently, and their occurrence seems to increase with 
age. Pulmonary arteriole thickening has been reported, 
and there are several reports of cor pulmonale in sickle 
cell patients. However, the data in this area are very 
limited. Much mere information on the pathologic findings 




Two approaches were taken to examining the effect 
of sickle cell disease on pulmonary function. First, 
clinical data for those patients followed at Yale-New Haven 
Hospital was analyzed. The incidence of acute pulmonary 
disease and the signs and symptoms of these episodes were 
looked at. As no data has been reported on the frequency 
and characteristics of acute pulmonary disease in the 
adult patient with sickle cell disease, this was of 
particular interest. Others have reported a dramatically 
increased incidence of pulmonary disease in populations 
largely made up of children, and it was of interest if 
this increase would also be observed in adults. Secondly, 
as pulmonary function studies have been inconclusive, a 
series of measurements of pulmonary function was done on 
ten patients with sickle cell disease. The next section 
of this paper will present these studies and their results 
which demonstrate a high incidence of acute pulmonary 
disease and definite abnormalities in pulmonary function. 

Materials and Metnods 
Clinical Data: 28 Patients with Sickle Cell Disease 
The hospital charts of all adults with sickle cell 
disease, SS, SC, and S-Thalessemia, were reviewed at 
Yale-New Haven Hospital during the period of .1970 to 1978. 
Charts were reviewed in their entirety, so that data is 
drawn from the entire period each patient was followed 
at Yale-New Haven Hospital. Ail patients greater than 
15 years of age were considered adults. The diagnosis 
of sickle cell disease was based upon hemoglobin electro¬ 
phoresis, the presence of anemia, and the family genetic 
history. The records of 34 patients were reviewed. Of 
these 34, two patients were eliminated from the study due 
to primary pulmonary disease (tuberculosis and sarcoid). 
Another four patients were excluded as they are followed 
primarily at other hospitals. 
Twenty women and eight men comprised the patient 
group studied. The patients ranged from 17 to 65 years 
of age, mean age 28. Seventeen of the patients had SS 
disease, 12 women and five men; six patients had S- 
Thalessemia; the remaining five women haa SC disease. 
Patients were first seen at Yale-New Haven Hospital 
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within the period from 1949 to 1978, and were followed 
for a total of 3 39 patient-years (mean follow-up .12 years) . 
Of the 339 patient-years, 113 were when these patients 
were in the pediatric age group (15 years or younger) and 
225 were during adulthood. The mean follow-up period for 
patients seen during the pediatric period and adult period 
was similar—-eight years. Since all patients were 
selected as adults, the pediatric data are mostly from 
late childhood, although some of the patients have been 
followed since birth. 
Pulmonary Function Studies Protocol 
All patients who could be contacted were asked to 
participate in a study of pulmonary function approved by 
the Yale University School cf Medicine Human Investigation 
Committee. Nine females and one male agreed to do pul¬ 
monary function tests. Of these ten subjects, five had 
SS disease, three S-Thalessemia, and two SC. The age 
range of the ten patients was 21 to 38, average 26. A 
clinical history including respiratory symptoms and 
smoking and occupational history, was obtained for each 
subject. A physical examination was done prior to the 
tests. 
Hemoglobins were measured. Posterior-anterior and 
lateral chest radiographs were obtained on the day of 
testing if a baseline chest radiograph was not available. 
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from the previous two months. 
Lung volumes were determined using the helium dilution 
technique, and were done with the Collins Maxi-Survey 
Computer System using a Stead-Wells eight liter spirometer. 
Maximum expiratory flow volume (MEFV) curves were 
done on a flow volume device-~a pneumotachygraph inter- 
gratory system of Virulto and Bouhuys (1973) and a Brush 
500 high performance calibrator was used to calibrate the 
pneumotachygraph for air and helium. First, the subject 
breathed air in performing the MEFV curves, and then 
repeated the test breathing an 80% helium-20% oxygen 
mixture. Each set of curves (helium-oxygen and air) was 
repeated at least three times, and the curves were repro¬ 
ducible. Maximum expiratory flow rate at 50% vital 
capacity (MEF^^Air), forced expiratory volume in 3. second 
(FEV^), and forced vital capacity (FVC) were determined 
from the air flow volume curves. The MEFrri for helium 
(MEF^^He) was determined from the MEFV curves breathing 
helium. 
The flow rate response at 50% of the FVC breathing 
helium compared to air was expressed as aMEF-^helium. 
MEFV nHe - MEF[-f Air 
AMEF He = -—---—- X 10 0 
MEF'5QAir 
A A,MEF5C|He of less than 20% was interpreted as suggestive 
of small airway disease (Dosman et al„, 1975; Despas et 
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al., 1972) . 
The diffusing capacity for carbon monoxide (DLCO) 
was determined using the single breath method of Gaensler 
and Smith (1973). 
Arterial blood gases were- obtained at rest breathing 
room air in a sitting position. Following infiltration 
of the skin over the radial artery with xylocaine, a 21 
gauge needle was inserted into the artery and a sample 
obtained. The arterial blood gases were repeated following 
20 minutes of breathing 100% oxygen via a demand valve 
with a mouthpiece. All measurements were made immediately 
after obtaining the blood samples. 
Alveolar-arterial (A-a) oxygen gradient was determined 
using the following equation: 
PA°2 = PI°2 " (PaC02 X 1*25) 
then, (A-a) = PA02 - Pa02 Cherniak (1977) 
where: P^C>2 = alveolar 02, p 0o = 
inspired O-, P Cb = arterial 0„, 
z a 2 
end PaC02 = arterial C02. 
Predicted normals for (A-a) oxygen gradient were taken 
from Mellemgaard's measurements in a healthy population 
(Mellemgaard, 1966). 
The magnitude of the intrapulmonary shunt was cal¬ 
culated as follows using arterial blood gases obtained 
-r 
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while the subject was breathing 100% oxygen (minimum of 
20 minutes): 
Qs C (c' - a) 02 
* 
Qt c (c* - v) 02 
c * 
where: 0 = shunt blood flow, Qm = total blood flow, 
s T 
Cc' = endcapillary 0-... C - arterial 00 , and 
°2 2 a°2 
Cv^ = venous 0-,. An a.-v oxygen content 
difference of 5 ml/100 ml is assumed (Cherniak, 
1977) . 
Predicted normal values for FVC, FEV^, and MEF^^ 
were from Higgins and Keller (1973). Predicted values 
for functional residual capacity (FRC) were from Bates et 
al. (1971), and for residual volume (RV) from Goldman and 
Becklake (1959). Predicted DLCO was from Gaensler and 
Wright (1966), and was corrected for anemia using the 
equation of Dinakara et al. (1970). All predicted values 
for lung volumes, flow-volume measurements, and DLCO 
were adjust by a factor of 0.85 to account for racial 
difference (Binder et al., 1976). 
Predicted values for arterial blood gases were 
calculated from the equation of Bates et al. (1971). 
Informed consent was obtained prior to the study with 
a research protocol approved by the Yale University School 
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of Medicine Human Investigation Committee. 
Re s ult s 
Clinical Data: 28 Patients with Sickle Cell Disease 
(Tables III-VI) 
A total of 62 episodes of acute pulmonary disease 
were diagnosed over a period of 339 patient-years (see 
Table III). Thirty-three of the episodes were pneumonia; 
nine pulmonary infarction or embolism; nine acute 
bronchitis; six were of unknown etiology, likely pneumonia 
or infarction; and one each was pleurodynia, "pneumo¬ 
nitis," and pharyngitis. The latter case was included 
because of a chest radiograph infiltrate. In all cases 
in which pulmonary infarction or pulmonary embolism (from 
here on these will all be referred to as pulmonary infarc¬ 
tion) was diagnosed, there was no evidence of deep vein 
thrombophlebitis. Other possible sources of emboli in 
these patients are fat and marrow from the marrow cavity 
and thrombi of sickied cells. All of these would arise 
as a result of an ongoing crisis. In situ sickling in 
the lungs is also a possible etiology. 
Thus, the incidence of acute pulmonary disease in 
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every 5.5 years. Twenty-five of these episodes were 
diagnosed and treated in the emergency room. This included 
11 episodes of pneumonia in the pediatric group and one 
in an adult. There were 21 cases of pneumonia necessi¬ 
tating hospitalization. Three of these were in children 
and 18 in adults. Overall, pneumonia was diagnosed at 
an approximately equal frequency in children and adults, 
once every 8.1 and 11.9 patient-years respectively. At 
the same time, the rate of hospitalization, for crisis in 
the same population was once every 3.3 patient years (see 
Table IV). 
Of the nine episodes of pulmonary infarction, four 
were diagnosed in children (all in the same patient, D. 
H.) and five in adults. The diagnosis was based on exclu¬ 
sion of other causes (e.g. pneumonia) and on an appropriate 
clinical picture consisting of presence of crisis and 
symptoms of pulmonary disease. The characteristics of 
these nine episodes will be discussed in more detail. 
Management 
In the management of these patients hydration and 
analgesics were used whenever crisis accompanied the 
acute pulmonary episode. In addition oxygen and anti¬ 
biotics were used when pneumonia was suspected. Arterial 

Table IV Incidence of Pulmonary Disease in Sickle Cell 































*Treated in emergency room and released* 
Total number of cases* 
3 Acute pulmonary disease* etiology unknown* 
^ Includes pneumonitis* pleurodynia, and pharyngitis. The 
latter included because of acute chest x-ray infiltrate* 
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blood gas determinations were employed in management of 
only one third of the adult in-patients with acute 
pulmonary disease, and were obtained in none of the 
pediatric patients, and in none of: the outpatients. 
Transfusion was employed in the treatment of 23% of the 
total episodes, and 29% of these transfusions were partial 
exchange transfusions. Ninety-three percent of the 
patients were performed on adults. Sixty-four percent of 
the patients transfused were concurrently in crisis. 
Forty percent of adult inpatients were treated with trans¬ 
fusion in addition to other modes of therapy. 
Signs and Symptoms of Pneumonia Versus Infarction 
In order to better define the characteristics of 
pneumonia in the sickle cell patient a scale was set up 
to make a more definitive diagnosis (see Table V). As 
illustrated in the table, points were assigned to various 
signs and symptoms of pneumonia. The highest ratings 
were assigned to the most diagnostic signs and symptoms 
with a positive sputum culture (for a pathogen) and a 
positive mycoplasma titer receiving the highest, number of 
points. Using this scale, all 62 episodes were evaluated. 
Points were deducted for the presence of crisis and 
hemoptysis, even though pneumonia and crises may be 

Table V,s —Scale for evaluating acute pulmonary episodes in 
patients with sickle cell anemia* Score of greater than five 
indicative of pneumonias 
Sign/symptom Point_Vsl ue 
Productive cough 1 
Onset Chill 3 
Discrete ehesfc radiograph 
infiltrate 2 




5% or more bands ,3 
Positive Cram Stain 2 
Positive Culture for 
Pathogen 5 
Positive Mycoplasma Titer 
Crisis 
Hemoptysis 




concurrently present. For nine of the cases there was 
insufficient data to evaluate on this scale. Using five 
points as a cut-off, all cases with a score greater than 
this were considered to have pneumonia. Seventy-three 
percent (22 or 30) cases with discharge diagnoses of 
pneumonia fulfilled the criteria of the scale for pneumonia 
by having more than five points. Three of the other cases 
with discharge diagnoses of pneumonia lacked sufficient 
data to be evaluated on the scale. Another five cases 
with discharge diagnoses of pneumonia when evaluated on 
the scale had a total of five or fewer points. These 
eight cases with discharge diagnoses of pneumonia which 
either had insufficient data or failed to fulfill the 
criteria of the scale were not considered in the analysis 
of the frequency of signs and symptoms. 
In addition to the 22 cases of pneumonia, three cases 
of bronchitis and two of unknown diagnosis had more than a 
score of five. The bronchitis cases were omitted from the 
analysis. All nine cases which had been diagnosed as 
pulmonary infarction had five or fewer points. 
The average age of the patients with pneumonia was 
22 with a range of one to 49. Two-thirds of the cases 
were admitted to Yale-New Haven Hospital; the remaining 
one-third were treated in the emergency room. Seventy- 
five percent of those treated in the emergency room were 




The signs and symptoms of these 22 cases of pneumonia 
defined as above, were examined (Table VI). Twenty-nine 
percent of the patients had an antecedent URI. Forty-two 
percent had a concurrent crisis and 25% had an onset chill 
with their pneumonia. Pleuritic chest pain was present in 
33% and hemoptysis occurred in one patient. While 54% had 
a history of previous pneumonia, just over 12% had a history 
of pulmonary infarction. The most common presenting 
symptom was productive cough which occurred in two-thirds 
of the patients. Although only one-fourth of the patients 
had an onset chill, it was a highly reliable symptom for 
pneumonia, and gram stains and/or cultures were positive 
in two-thirds (two of five) of the cases. Cultures were 
positive for Diplococcus pneumonia twice and for Hemo¬ 
philus influenza once in those presenting with a chill. 
Two-thirds of those with onset chill were adults. 
Significantly over 37% of the patients were afebrile 
on presentation, though all but two went on to develop 
fever. The mean duration of fever with treatment was 
5.3 +/~2.9 days (mean +/- S.D.). The average length 
of hospitalization was 10.1 H-/-4.9 days. The mean 
white count on presentation was 24,000, but there was 
3 
a large range from .11,2 00 to 56,250/mm . A left 
shift was not consistently present on presentation. The 
average percentage of bands was 10.8 +/-S.4. 

Table VT—»Frequency of signs and symptoms in pneumonia and 
in pulmonary infarction in patients with sickle cell 
disease cn presentation,. 
* 
sign/symptom Pneumonia(24) Pulmonary In 
Fever 62% (15) 33$ (3) 
Crisis 42 % (10) 89$ (8) 
Productive Cough 6?% (16} 0% (0) 
Hemoptysis k% (1) 0% (0) 
Onset Chill 21% (5) 0% (0) 
Proceeding URI 29% (7) 11# M \ \ X j 
Pleuritic Chest Pain 33$ (8) 33$ (3) 
History of Pneumonia ku% (13) (:>2% (6) 
History of Pulmonary 
Xn&rction 12% (3) 44$ (4) 
History of Oral 
Contraceptive Use 0% (0) 1 <iC? X 1/3 U) 
Chest Radiograph InfiltratelOO# (24) (2) 
Multilobe Involvement on 
Chest Radiograph 
1 
(9) 0% (0) 
Pleural Effusion k% (i) 33% (3) 
White Blood Call Count 
Above 159000 (19) 100% (9) 
Differential Count 
5% or mere Bands 
** 
77% (19) 44$ (4) 











Figures in parentheses are total numbs rs of pat lent s 
t-tsetur' •r^cuto-x&tnim 
These two groups are not identical, some patients had wleft 
shifts” and no elevation of white count and vice versa, 
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The chest radiograph showed an infiltrate in all 
patients. In over 37% there was multilobar involvement. 
Only one of 24 patients had a pleural effusion. 
Gram stains were positive in only six of the cases. 
Of these half grew pathogens. Cultures from an additional 
tv/o patients were positive. The organisms isolated were 
Diplococcus pneumoniae (three patients) , Haemophilus 
influenza (one patient), and Staphylococcus aureus (one 
patient). Two of the culture positive cases of Diplococcus 
pneumoniae were in adults, the other in a child. 
For comparison data from the nine patients diagnosed 
as having pulmonary infarction or embolism without 
pneumonia, all of whom came in on the low end of the 
evaluating scale, were analyzed. One of the nine had an 
antecedent URI. 89% presented with concurrent crisis. 
Pleuritic chest pain was present in one third. None had 
a productive cough, and none had hemoptysis. Sixty-seven 
percent had a history of pneumonia and 44% had a history 
of pulmonary infarction. One patient was taking oral 
contraceptives. 
All patients with a diagnosis of pulmonary infarction 
were hospitalized for their illness. The mean age was 25 
with a range of 12 to 42. The average length of stay was 
9 +/- 4 days. Two-thirds were afebrile on presentation. 
Four patients had low-grade fevers during hospitalization, 
and the average duration of fever for these patients was 
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5 +/-2 days. 
The average white blood count on presentation was 
22,iOO/mm^ with a range of 19,900 to 31,7GG/mm^ . Four of 
the nine patients had a left shift in their differential, 
and in two of these the shift was marked--20 and 30% bands 
respectively. The mean percentage of bands for all nine 
patients on presentation was 7.4%. 
Reticulocyte counts were examined in view that 
reticulocytosis might be suppressed in the presence of 
infection and normal or elevated with infarction. The 
average count was 17 -f/-13% while the average was 20,8 
+/-18.7% in patients with pneumonia. 
Bilirubin was elevated in the group with pulmonary 
infarction, but not consistently: mean direct was 1,74 
mg/100 ml, mean total 2.75 gm/'100 ml. Bilirubin was 
lower in those with pneumonia: mean direct 0.62 mg/100 ml, 
mean total 2.57 mg/100 ml, but values were not consistently 
different from the values seen in patients with pulmonary 
infarction. 
One-third of the patients with pulmonary infarction 
had clear chest radiographs. Another one-third of these 
nine patients had pleural effusions. The chest radio¬ 
graph of only one patient demonstrated the classic wedge- 
shaped infiltrate of pulmonary infarction. Two chest 
radiographs showed plate-iike atelectasis, and one 




Chest Radiograph Findings in Asymptomatic SickIers 
Of the 28 patients whose records were reviewed, one 
had evidence of pulmonary hypertension on chest radiograph 
indicated by prominence of the main pulmonary artery and 
redistribution of blood flow to the upper lung zones. 
This patient, a 28 year old woman, had had a severe 
course of sickle cell anemia with a history of 26 episodes 
of hospitalization for crisis and five hospitalizations 
for acute pulmonary disease. She declined to be studied. 
One other patient, a 22 year old woman, had a borderline 
increase in the prominence of the main pulmonary artery 
on chest radiograph, which was suggestive of possible 
pulmonary hypertension, but not diagnostically definite. 
Pulmonary Function Studies: Ten Patients with Sickle Cell 
Disease (Tables VII to XI) 
The mean age of the ten patients studied was 26. 
Nine of those studied have been followed for a total of 
122 patient-years--48 pediatric and 74 adult. One 
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is not included here. During the period they were 
hollowed at Yale-New Haven Hospital these patients were 
hospitalized 28 times for crises and had 23 episodes of 
acute pulmonary disease (pneumonia, pulmonary infarction, 
and bronchitis as discharge diagnosis). Fourteen of 
these episodes necessitated hospitalization. Three 
patients including both with SC disease and one with SS 
and 18% F hemoglobin had never been hospitalized for 
crisis. Two patients had never had an episode of pul¬ 
monary disease. 
All patients were asymptomatic and denied cough or 
dyspnea. There was no history of occupational exposure 
to known pulmonary toxins in any of the patients. Eight 
of the ten patients were smokers; seven smoked one-half 
pack of cigarettes per day or less. All patients were 
free of acute pulmonary disease at the time of the study. 
Physical examinations were unremarkable except for the 
presence of soft (grade 1 to II on a scale of VI) systolic 
ejection murmurs, which were heard at the lower left 
sternal border and were nonradiating, in six patients. 
The mean hemoglobin of the ten patients was 10.1 
+/-2.2 mg% (see Table VII). The mean percentage of F 
hemoglobin was 9.1%. Chest radiographs were normal 
except for cardicmegaly in four of the patients. 
Lung volume measurements (see Table IX) demonstrated 
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nine patients and increased in one patient. The 
residual volume was reduced in four subjects and elevated 
in one. 
Forced vital capacity (FVC) and FEV1 were normal in 
nine out of ten patients. One patient had a decrease in 
FVC. The FEV-j /FVC ratio was normal for all subjects, 
MEFrn (air) was decreased in four patients. 
5 0 
Three of nine patients had a AMEF,..He of less than 
3 U 
20%, values for the remaining six patients were normal. 
Measurements of the diffusing capacity for carbon 
monoxide showed the corrected DLCO (see Table X) to be 
normal in all but one subject. 
Sixty percent (six of ten) of the subjects had an 
arterial P00 while breathing room air- which was less than 
85% the predicted value (Table XI). The (A-a) 0„ gradient 
was increased in all patients. The mean value for the 20 
to 29 age group (nine of 10 subjects) was 31.86 +/-9.61. 
The tenth subject who was in her late thirties also had 
an abnormally increased gradient of 19.75 (see Table X). 
Six patients were tested for the presence of 
shunting. • A normal physiologic shunt is considered to 
be five percent or less (West, 1977). An abnormal degree 
of intrapulmonary shunting was present in all six of these 
patients with a mean calculated shunt of 10,3 +/-1.5% 
(Table X). 

Table X Helium Flow Studies and DLCO 
Fatlent 
A Vffiax5oHe 
DLCO ' JC Fred 
S.E. 21 18,4 95 
S • n * 22 27.2 140 
D.H. 39 ““ 
F. M, 1? 23,6 162 
E.T. 32 23.9 116 
S. Bi ® 8 14,9 73 
J. C. 22 26*5 141 
B.K. 1.6? 22,1 102 
H.S. 32 21.6 133 
E.D. *CVia* 34,9 100 
A AV'max^Q of 20$ or more is considered normal {see text)® 
’ it 
This represents corrected DLCO, as outlined in materials 
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This review of the Yale-New Haven Hospital population 
of sickle cell patients establishes for the first time the 
incidence and characteristics of acute pulmonary disease- 
in an adult population of sicklers. The characteristics 
of acute pulmonary disease in our overall population 
differ somewhat from those reported in the literature. 
During the period they (both as adults and as children) 
were followed, our patients were hospitalized 103 times 
for crises and only 37 times for acute pulmonary episodes. 
In contrast, in Barrett-Connor1s population acute 
pulmonary disease was the most frequent cause for hospi¬ 
talization. Even if all episodes of acute pulmonary 
disease are included, emergency room treated as well as 
those necessitating hospitalization, the incidence of 
pulmonary disease remains less than the incidence of 
crisis necessitating hospitalization. 
The overall incidence of pneumonia was less in our 
population than in Barrett-Connor's population (1971-a), 
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but greater than that in Henderson's population (1950). 
Barrett-Connor (1371-a) found 169 episodes of pneumonia 
requiring hospitalization over a period of 864 patient- 
years, --or one case every 5.1 patient-years. In contrast 
in our population there were only 21 hospitalizations with 
a diagnosis of pneumonia over 339 patient-years, or one 
case every 16.1 patient-years. Even if we include all 
cases of pneumonia, .hospitalized as well as those treated 
as outpatients the figure only rises to one episode every 
10.2 patient-years. One reason for this difference is 
the age of the populations. The mean age of Barrett- 
Connor' s population was 12 years with a range of seven 
wests to 47 years, while the mean age of our population 
was 28 with a range of 17 to 65. Looking at adults 
alone, we find an incidence of hospitalization for 
pneumonia of once every 12.5 patient-years. We might 
explain the difference then on the basis of different 
age groups. However, the incidence of pneumonia in our 
patients during the periods of their childhoods when they 
were followed here (a total of 113 patient-years) is 
only one episode of hospitalization for pneumonia every 
37.8 years. A'key to the difference in frequency may 
lie in Barrett-Connor ’ s population having a greiiter 
proportion of young children. She has found that the 
incidence of pneumonia under five years of age in this 
population is significant, and that pneumonia before age 
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five makes later episodes more likely. Only two of our 
patients are known to have had pneumonia before age five, 
and these two patients combined have had a total of ten 
episodes of acute pulmonary disease over a follow-up 
period of 36.4 patient-years. 
Another factor influencing the frequency of pulmonary 
disease in our population is that it is a somewhat tran¬ 
sient population with a certain degree of movement between 
Connecticut and the South. Where possible, the total 
follow-up period was adjusted to not include periods where 
it was clearly indicated in the chart that the patient 
had been residing in the South. Since it was not always 
possible to determine from the chart if a patient was 
continuously present in the New Haven area, this may have 
made the figures for the years of follow-up falsely high 
and also have made the incidence of acute pulmonary disease 
falsely low. There is no way of determining if a patient 
was well for a one or two year period or if he was living 
in another area at that time, and perhaps even having 
episodes of pulmonary disease. Thus, our figures may 
underestimate the incidence of acute pulmonary disease. 
The frequency of crises accompanying pneumonia 
(42%) is less than that of Henderson (1950) who observed 
it in 13 of 14 cases, and greater than that of Barrett- 
Connor (1971-a) who observed crisis in only one quarter 
of the patients with pneumonia. Crisis in our population 
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more frequently accompanied pulmonary infarction, but the 
presence of crisis does not rule out the possibility of 
pneumonia. 
The most reliable factors in distinguishing pneumonia 
from infarction in our population were productive cough, 
onset chill, and multi-lobe involvement on chest radio¬ 
graph. Pleural effusion favored pulmonary infarction. 
Of note, the absence of fever on presentation is not a 
reliable sign of the absence of infection, for 48% of 
our patients with pneumonia were afebrile on presentation. 
On the other hand, one third of those with infarction were 
febrile. 
The white blood cell count and its differential 
cannot be relied upon alone to distinguish between 
infection and infarction. The wide range of white blood 
cell counts observed in our population concurs with the 
findings of others (Petch et al., 1970). There is much 
overlap between the white blood cell counts found in 
infection and infarction. Patients with pulmonary in¬ 
farction can present with high white blood cell counts 
and "left shifts." Rather it is the clinical picture as 
a whole, not any one single aspect, which must be examined 
in order to make the difficult diagnostic distinction 
between pneumonia and pulmonary infarction in the sickle 
cell patient. Furthermore, the possibility that the two 
entities can co-exist and that in situ sickling in the 
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lungs can potentially complicate the picture, must be 
kept in mind. 
In contrast to other investigators (Fetch and 
Serjeant, 1970; Fetch et al., 1970; Henderson, 1950), we 
found a prolonged fever course to be uncommon with the 
mean in our patients with pneumonia being five days with 
treatment. Cultures were very frequently negative, even 
in the presence of a clinical setting strongly favoring 
the diagnosis of pneumonia. 
Barrett-Connor observed that jaundice and the 
elevation of bilirubin above five occurred in four of 
five of her patients with pulmonary infarction. In cur 
population only two of nine patients with pulmonary infarc¬ 
tion had a bilirubin above five mg%, while two of ten 
with pneumonia for whom values are available had eleva¬ 
tions of bilirubin above five mg%. Bilirubin levels in 
our patients were not reliable in distinguishing pneumonia 
from pulmonary infarction. 
Pulmonary Function Studies 
The pulmonary function studies demonstrate that 
pulmonary dysfunction is common in sickle cell patients 
even in the absence of symptoms, and even in the presence 
of clinically mild sickle cell disease. All of the 
patients tested had abnormalities in pulmonary function. 
-i 
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Impaired oxygenation of the blood was present in all 
patients„ 
Arterial PO^ was decreased in 60% of the patients 
studied. The (A-a)O^ gradient was found to be markedly 
increased in all subjects, which confirms the findings of 
other investigators (Bromberg and Jensen, 1967)„ The 
(A-a)©^ gradient was more consistently increased in our 
population than in the patients studied by Bromberg and 
Jensen. This increase in the (A-aJO^ gradient with a 
normal DLCO may be due to a reduction in the pulmonary 
vascular bed and consequent decrease in the transit time 
across the. pulmonary capillary bed and/or a V/O mismatch. 
A number of earlier investigators found DLCO to be 
consistently low (Bromberg and Jensen, 1967; Young et al., 
1976; Femi-Pearse et al., 1970). However, none of these 
investigators corrected their measurements for their 
subjects' anemia. Corrected DLCO was normal to increased 
in all our subjects except one. 
Of interest is the marked abnormality of the (A-aJO^ 
gradient in the three patients in the study who have 
milder sickle cell disease, never having been hospitalized 
for crisis, and one of whom never had any known pulmonary 
disease. 
In the six patients in which the determination of 
intrapulmonary shunting was done after breathing 100% 
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oxygen, the mean shunt in these patients was 10.3% which 
is markedly abnormal. This supports the finding of 
Bromberg and Jensen of a nonphysiologic degree of shunting 
in a number of their patients (1967). 
One third of our patients had evidence of small air¬ 
way disease. This is in contrast to Young et. al. (197 6) 
who using a different technique (closing volumes) found 
the small airways to be normal in the subjects they tested. 
However, most of the subjects in our study were smokers, 
and smokers have been shown to have small airway disease. 
The pulmonary function studies demonstrated no 
consistent abnormality in lung volumes or in flow-volume 
parameters. TLC was normal in two-thirds of the patients. 
FVC was normal in 80% of the subjects studied. These 
results differ from those found by other investigators. 
FVC was found to be abnormally low by both Young et al. 
(1S76) and by Miller and Serjeant (1971). These investi¬ 
gators along with others also found TLC to be reduced 
(Diggs, 1969; Femi-Pearse et al., 1970; Bromberg and 
Jensen, 1967). While we found RV/TLC to be reduced in 
one-third of our subjects. Miller and Serjeant found it 
to be increased (1971). 
Flow-volume studies showed FEV-^ to be normal in all 
but one subject. Miller and Serjeant had found FEVn to 
_L 
be normal in females, which most of our subject group 
were, and reduced in males. FEV./FVC was normal in all 1 

subjects studied. This agrees with the findings of Young 
et al. (1976) and Miller and Serjeant (1971). MEF_n was 
reduced in four of the subjects we studied. 
A key factor in determining whether a subject has 
normal pulmonary function is defining what normal is for 
that individual. In determining the predicted normal for 
a subject in addition to taking into account the variable 
of age, height, and sex, it is critical to correct for 
race. Pulmonary function tests for blacks and Caucasians 
matched for the usual variables are not identical, and 
could be corrected by a factor of 0.85 (Binder et al, 
1976). Miller and Serjeant in their study used Jamaicans 
of African descent as controls for their patients who were 
of the same racial origin. Some of the difference between 
their observations and those reported here may be related 
to differences between the population of American blacks 
with sickle cell anemia and Jamaicans with sickle cel-l 
«r 
anemia. 
The consistent pulmonary abnormalities we found were 
a reduced arterial PO?. an increased (A-a'/O^ gradient, and 
a nonphysiologic degree, of intrapulmonary shunting. There 
is a possibility of small airway disease, but this needs 
to be confirmed with studies in nonsmoking sickle cell 
patients. We did not find any consistent abnormality in 
lung volumes or in flow rates. In a minority of individual 
lung volume and flow-volume tests were suggestive of a 

67 
restrictive ventilatory defect. The majority of these 
parameters, though, were normal in the patients studied, 
in contrast to earlier studies. 
The population studied was relatively young with a 
mean age of 26. Our subjects had a. high percentage of F 
hemoglobin (mean 9.1%). Their young age and their high 
percentage of F hemoglobin both may contribute to making 
this population less likely to have severe pulmonary 
disease. However, that there is definite evidence of 
impaired gas exchange in these patients who are healthier 
than the overall sickle cell population at Yale-New Haven 
Hospital, argues that an even greater degree of pulmonary 
disease may be present in the sickle cell population as a 
whole. 
The impairment of gas exchange demonstrated in these 
studies may be due to the hypothesized multiple insults 
occurring in the lungs as a result of embolization of 
sicklea cells, fat, and marrow during crises, of in situ 
sicking in the lungs both as a manifestation of crisis and 
as a potential complication of infection. 
One of the patients in the total population of 28 has 
evidence of pulmonary hypertension on. chest radiograph, 
and a second has changes suggestive cf pulmonary hypertension. 
The long term course in the development of pulmonary hyper¬ 
tension and impairment of pulmonary function needs to be 
further evaluated. Our results indicate that arterial 
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blood gases and/or the (A-aJO.-, gradient, and the degree 
of intrapulmonary shunting are the lung function tests 
that are useful to follow in these patients. 
Conclusions 
The pulmonary function studies demonstrate an impair¬ 
ment of gas exchange indicated by an increased (A~a)0„ 
gradient and reduced arterial oxygen tension at rest. 
These results support the hypothesized chronic series of 
insults to the lung in the form of emboli accompanying 
crisis and of iri situ sickling. Mere studies are needed 
to better elucidate whether scarring of the alveolar- 
capillary membrane (less likely with a normal DLCO) or 
obliteration of the pulmonary vascular bed secondary to 
chronic embolization and sickling, or some other mechanism 
is responsible for the abnormal gas exchange seen in these 
patients. 
Pulmonary function studies show intrapulmonary shunt¬ 
ing and small airway disease, though the latter could be 
due to cigarette smoking. Some evidence of restrictive 
disease was present in the lung volume studies, but 
this was far from conclusive and more studies are needed 
on more patients to clarify whether restrictive disease 
develops in these patients. 

The clinical review presented here demonstrates that 
there is a high incidence of acute pulmonary disease and of 
pneumonia alone in the sickle cell population. Our find¬ 
ings indicate that the rate of pneumonia in the adult with 
sickle cell disease is high, but lower than the incidence 
in children with sickle cell disease. 
Parameters which can help distinguish between pneu¬ 
monia and pulmonary infarction have been outlined. No 
single sign or symptom is pathognomonic for either entity 
in the patient with sickle cell disease. The definitive 
study in the diagnosis of pulmonary infarction and embolism 
is pulmonary angiography, but in a population already at 
risk for sickling, where this risk will be potentiated by 
the use of hypertonic contrast material, one is reluctant 
to increase the risk of sickling in the lungs without 
definite, tangible benefit to the patient. An alternative 
is the use of the gallium scan, and its use will be dis¬ 
cussed below. 
The diagnosis and management of the pulmonary infil¬ 
trate in the patient with sickle cell disease is clearly 
not straightforward. The differential diagnosis is 
between pulmonary infarction and pneumonia. All sickle 
cell patients with pulmonary infiltrates and/or lower 
respiratory tract symptoms (e.g. cough) if sick enough to 
be admitted to the hospital, should have arterial blood 
gases drawn (on room air) and sputum obtained for gram 
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stain and culture. Sickle cell crisis should be treated 
vigorously in the usual manner with oxygen, hydration, 
analgesics, and. transfusion and/or exchange transfusion 
as the clinical situation dictates. With their funtionai 
asplenia and impaired white blood cell function sicklers 
can potentially have overwhelming infections. That 
pulmonary infection and infarction can coexist in the 
lungs must be kept: in mind. The initiation of antibiotic 
treatment will depend on the clinical history, physical 
findings, and laboratory studies including sputum gram 
stains and cultures. 
At the present time we are conducting further studies 
to delineate whether the pulmonary infiltrate is due to 
an inflammatory process such as pneumonia or to pulmonary 
infarction. This can be done with a gallium scan of the 
lungs followed by a V/Q scan (Nider et al., 1977). The 
infiltrate of a pneumonia will be positive with a gallium 
scan, while a V/Q mismatch should be seen with pulmonary 
infarction. These two tests are relatively noninvasive 
and avoid the risk of pulmonary angiography. Better 
elucidation of the underlying pathophysiology in the acute 
pulmonary episode in the patient with sickle ceil disease 
will facilitate a more rational approach to diagnosis and 
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